Correction to: Challenges and progress of neurodrug: bioactivities, production and delivery strategies of nerve growth factor protein
Nan Zhou, TingWei Gu, Yang Xu, Yuda Liu, LiHua Peng
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNerve injury and regeneration · Axon Guidance and Neuronal Signaling · Neurological Disorders and Treatments
Correction to: J Biol Eng 17,*** 75 (2023).***
10.1186/s13036-023-00392-2
The original publication of this article omitted the proper attribution for 2 figures. This correction article is to provide the correct attribution for Figs. 4 and 6 and to provide the reference details of the original sources. The incorrect and correct information is shown in this correction article.
Incorrect
Fig. 4. The treatment of NGF for Alzheimer’s disease
Fig. 6. The treatment of NGF for optic nerve regeneration
Correct
Fig. 4. The treatment of NGF for Alzheimer’s disease. This figure was adapted from Fig. 1 from Mitra et al. (2019) [77]
Fig. 6. The treatment of NGF for optic nerve regeneration. This figure was adapted from Fig. 4 from Kwon et al. (2020) [78]
The original article has been updated. The authors apologize for these oversights and thank the editors, reviewers, and readers for their understanding.